Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC1A3 | P43003 | 1/20 | 0.43 |
| ▸ | SLC1A1 | P43005 | 1/20 | 0.43 |
| ▸ | MME | P08473 | 1/20 | 0.43 |
| ▸ | CTSL | P07711 | 5/20 | 0.43 |
| ▸ | ACE | P12821 | 6/20 | 0.43 |
| ▸ | CTSK | P43235 | 1/20 | 0.42 |
| ▸ | MMP3 | P08254 | 2/20 | 0.42 |
| ▸ | MMP2 | P08253 | 1/20 | 0.42 |
| ▸ | CTSB | P07858 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Leucine SCHEMBL7325203 | 0.87 | MMP2 (0.53) | SLC1A3SLC1A1MMECTSLCTSK | |
| Leucine SCHEMBL6418640 | 0.86 | SLC7A5 (0.44) | MMEACEMMP3MMP2 | |
| Leucine SCHEMBL7364033 | 0.86 | SLC7A5 (0.44) | MMEACEMMP3MMP2 | |
| SCHEMBL7322354 | 0.85 | MME (0.53) | MMECTSLACE | |
| Leucine SCHEMBL6412971 | 0.84 | MMP2 (0.50) | MMEACEMMP3MMP2 | |
| Leucine SCHEMBL7367908 | 0.80 | SLC7A5 (0.44) | MMEACEMMP3MMP2 | |
| Leucine SCHEMBL6411762 | 0.80 | SLC7A5 (0.44) | MMEACEMMP3MMP2 | |
| SCHEMBL10829372 | 0.78 | ACE (0.57) | ACE | |
| SCHEMBL9773173 | 0.78 | ACE (0.57) | ACE | |
| SCHEMBL9257644 | 0.78 | ACE (0.57) | ACE |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5932551-A | INHIBITORS OF MATRIX METALLOENDOPROTEINASE-MEDIATED DISEASES | MERCK & CO., INC. (US) | 1999-08-03 | — | — | US | disclosed |
| EP-0586537-A4 | SUBSTITUTED N-CARBOXYALKYLPEPTIDYL DERIVATIVES AS ANTIDEGENERATIVE ACTIVE AGENTS | MERCK & CO INC (US) | 1997-06-25 | — | — | EP | disclosed |
| EP-0586537-A1 | SUBSTITUTED N-CARBOXYALKYLPEPTIDYL DERIVATIVES AS ANTIDEGENERATIVE ACTIVE AGENTS | MERCK & CO. INC. (US) | 1994-03-16 | — | — | EP | disclosed |
| WO-1992021360-A1 | SUBSTITUTED N-CARBOXYALKYLPEPTIDYL DERIVATIVES AS ANTIDEGENERATIVE ACTIVE AGENTS | MERCK & CO., INC. (US) | 1992-12-10 | — | — | WO | disclosed |